all AI news
London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M (Ingrid Lunden/TechCrunch)
July 14, 2023, 2:15 a.m. |
Techmeme www.techmeme.com
Ingrid Lunden / TechCrunch:
London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M — Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery.
artificial biomedical causaly discovery drug discovery funding growth iconiq growth london research series series b techcrunch
More from www.techmeme.com / Techmeme
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US